PFM
AXDX

Premier Fund Managers’s Accelerate Diagnostics AXDX Stock Holding History

Premier Fund Managers’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-5,024
Closed -$375K – 221
2020
Q4 		$375K Hold
5,024
– – 0.02% 213
2020
Q3 		$542K Sell
5,024
-7,166
-59% -$995K 0.03% 197
2020
Q2 		$1.85M Buy
+12,190
New +$1.2M 0.11% 148

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Premier Fund Managers's AXDX Position: Q1 2021 in Review

Premier Fund Managers sold out of Accelerate Diagnostics (AXDX) in Q1 2021, closing a stake of 5,024 shares — an estimated $375K sold.

Premier Fund Managers first reported a position in AXDX in Q2 2020 and held it in 3 quarters. The position peaked at $1.85M in Q2 2020. 99 funds tracked by Wall St. Rank hold AXDX as of Q1 2021.

  • Premier Fund Managers reported no remaining Accelerate Diagnostics position as of Q1 2021 after selling out during the quarter.
  • Premier Fund Managers sold 5,024 Accelerate Diagnostics shares in Q1 2021, an estimated $375K.
  • Premier Fund Managers first reported a position in Accelerate Diagnostics in Q2 2020 and held it in 3 quarters.
  • Premier Fund Managers's Accelerate Diagnostics position peaked at $1.85M in Q2 2020.
  • 99 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q1 2021.

Based on Premier Fund Managers's 13F filing for Q1 2021, filed 10 May 2021.